CSL Ltd. (CSL.AX) News Headlines

▮ More

Date

Headline

6/22/2022 9:34:44 PM CDC Panel Recommends Older Adults Receive Enhanced Flu Vaccine, Incl. Fluad Quadrivalent

2/15/2022 9:05:24 PM CSL HY Profit Down

12/14/2021 2:00:36 AM Merck's HIV Trials Put On Clinical Hold, Vifor Gets A Suitor, VERU Scores FDA Nod...

12/14/2021 1:10:30 AM Australia's CSL Agrees To Buy Vifor Pharma For $11.7 Bln In Cash - Quick Facts

12/14/2021 12:50:39 AM CSL To Acquire Vifor Pharma For Aggregate Equity Value For Vifor Pharma Of $11.7/CHF 10.9 Bln

12/13/2021 12:17:35 AM Australia's CSL Confirms Takeover Talks With Swiss Drugmaker Vifor Pharma

12/13/2021 12:04:32 AM Australia's CSL Confirms Talks With Vifor Pharma Regarding Potential Acquisition

10/15/2021 1:34:18 PM FDA Approves Quadrivalent Influenza Vaccine Including Children Of Six Months

10/4/2021 9:12:34 AM Seqirus Bags $35 Mln U.S. Govt. Contract To Develop Two Pandemic Influenza Vaccines

8/18/2021 1:29:06 AM CSL FY21 Profit Rises, Declares Dividend; Sees Weak Profit In FY22; Stock Down

8/18/2021 1:01:49 AM CSL FY EPS $5.22, Up 10% At CC

2/17/2021 9:00:31 PM CSL HY Profit Rises

Older Articles

Csl Ltd. (CSL.AX)